Understanding the Real Impact of Cannabis on Cognition and Health

7 Crucial Facts About Medical Cannabis Safety for 2024

Medical cannabis has become a hot topic in both public and scientific discussions, particularly regarding its safety and impact on health. Medical cannabis safety is at the heart of the ongoing debate, with many patients and healthcare providers seeking clarity on its cognitive and long-term effects. A recent study sheds light on how cannabis affects the brain, cognition, and overall health, providing insights that are crucial for understanding its viability as a treatment in 2024 and beyond. The study essentially found that using medical cannabis in light to moderate amounts for a year didn’t cause any major changes in brain activity or cognitive function. Participants maintained stable memory, decision-making, and self-control without noticeable short-term side effects. However, since the study focused on a specific group, we still need more research to understand the long-term effects and how it applies to a broader population.

As medical cannabis becomes increasingly available, it’s ever more important to take a careful, skeptical, look at its implications—both positive and negative—on brain function, memory, and cognitive health. Below, we’ll break down seven key facts about medical cannabis safety, exploring what this study tells us and addressing important considerations that may have been overlooked.

Fact 1: Medical Cannabis Shows Minimal Cognitive Decline Over Time

One of the most important findings from the study is that medical cannabis safety appears to hold up in the short term, with no significant cognitive decline observed over a one-year period of moderate cannabis use. This is reassuring for patients using cannabis to manage symptoms like anxiety, pain, or insomnia.

The study participants, who were primarily light to moderate users of cannabis, showed no significant changes in brain activation during cognitive tasks such as working memory or inhibitory control. This suggests that cannabis, particularly CBD-dominant products, does not impair cognitive function when used in moderate doses by adults.

However, it’s worth noting that the study’s follow-up period of just one year may not be enough to capture long-term cognitive effects, especially if users increase their dosage over time. Tolerance to THC, for instance, is well-documented, and patients may need to escalate their intake for continued symptom relief, potentially leading to cognitive challenges down the line.

Fact 2: THC vs. CBD – Different Effects on the Brain

The study did not focus specifically on the differences between THC and CBD, but it’s crucial to understand how these two cannabinoids interact with the brain differently. THC, the psychoactive compound in cannabis, binds to CB1 receptors in the brain, which can cause memory impairment, reduced attention, and disrupted executive function. In contrast, CBD does not have psychoactive effects and may actually counteract some of THC’s negative impacts on the brain.

For medical cannabis safety, the balance between these two cannabinoids is key. Patients using CBD-dominant products likely face fewer cognitive risks than those using THC-heavy strains, especially over the long term.

The Doctor-Approved Cannabis Handbook, page 36

“Cannabinoids can also have a direct effect on nerve signaling, which governs thoughts, movement, and sensory function. You can think about your brain as the top of a pyramid, sending signals down that affect other systems throughout the body via the nervous system. Nerve signals begin as electrical impulses in the brain, and the endocannabinoid system has a powerful effect on this network, causing a slowing down of signaling. That’s why when you are using cannabis products, particularly those products that are high in THC, you may feel like you are moving more slowly, and, more importantly, you feel calmer and less hurried. Cannabinoid molecules mimic some of the natural hormones that our bodies produce. For instance, some cannabinoid molecules have the precise shape to fit into the same receptors to which opiates and narcotics bind. Although the effect of cannabinoids binding the mu opiate receptors is only a small fraction of the intensity of opiate medicines bonding there, we still feel slight levity with the cannabinoids without the typical consequences of the addictive narcotics. In fact, many patients who have been prescribed opiates for pain relief end up using far less medication when combined with cannabis products.”

Fact 3: Real-World Use vs. Controlled Lab Settings

This study stands out because it was conducted in a real-world setting, meaning participants chose their cannabis products from local dispensaries, much like actual medical users. While this makes the findings more applicable to everyday users, it also introduces a level of variability that could obscure more nuanced results. Different strains, dosages, and consumption methods (e.g., vaping vs. edibles) all affect how cannabis interacts with the brain and body.

Patients using cannabis for medical purposes should be aware of this variability and work closely with healthcare providers to find the right dosage and formulation for their specific needs. Standardization in medical cannabis remains a challenge, which is why regulation and ongoing research are vital to ensure medical cannabis safety across the board.

Fact 4: Medical Use Is Not Recreational Use

It’s important to differentiate between medical cannabis and recreational cannabis. Many of the negative cognitive effects associated with cannabis use—such as memory loss or executive dysfunction—are tied to heavy, recreational use, particularly in younger populations. In contrast, medical cannabis users are often older adults using the drug for symptom management under the guidance of a physician.

The study primarily involved older, White, and well-educated participants who began using cannabis in adulthood. These findings may not apply to younger users or those who began using cannabis recreationally during adolescence, when the brain is still developing. Adolescent cannabis use is known to have more significant long-term cognitive impacts.

Fact 5: Limited Applicability to Broader Populations

The study’s findings are based on a specific demographic: older adults using cannabis for medical reasons. This raises questions about applicability to broader populations, including younger individuals, minorities, and heavy recreational users. Medical cannabis safety in younger populations, especially those using cannabis with higher THC content, could present more risks.

For researchers and healthcare providers, this means more studies are needed that include diverse demographics, varying cannabis use patterns, and longer-term follow-up periods to fully understand the impact of cannabis across different groups.

Fact 6: Potential for Long-Term Risks

While the study found no significant cognitive decline over the course of a year, we must acknowledge that long-term effects may still emerge with prolonged use, especially if patients develop tolerance and increase their dosage. THC-heavy products, in particular, may lead to dependence or addiction over time, which could have lasting cognitive consequences.

For healthcare providers, monitoring patient use and ensuring responsible consumption is critical to maintaining medical cannabis safety over the long term. Patients should be educated on the potential risks of dose escalation and work with their physicians to adjust their treatment plans as needed.

Fact 7: The Need for Standardized Dosing and Regulation

One of the challenges highlighted by this study is the lack of standardized dosing in medical cannabis. Since participants selected their own products from dispensaries, there was considerable variation in cannabinoid content and consumption methods. This underscores the need for better regulation and standardization of medical cannabis products to ensure consistent, safe use across the board.

Until these standards are established, patients and clinicians must work together to find the right balance of cannabinoids and consumption methods that provide symptom relief without compromising medical cannabis safety.

A Final Thought on Medical Cannabis Safety

As the use of cannabis becomes more widespread, understanding its true impact on cognition and health is more important than ever. This study offers encouraging evidence that moderate use of medical cannabis may be safe for many adults, but we must remain vigilant about the long-term effects, especially in younger or heavier users. Moving forward, regulation, standardization, and patient education will be crucial to ensuring that cannabis remains a viable therapeutic option for those who need it most.

Salient Statistical Points:

The study revealed no significant cognitive decline among light to moderate cannabis users over the course of one year. However, it’s important to note that the participant group was primarily made up of older, White, and well-educated individuals, which limits the generalizability of the findings. Additionally, the study did not control for the cannabinoid ratios, meaning participants used cannabis products with varying balances of THC and CBD. This variability, combined with the study’s relatively small sample size, also limited the researchers’ ability to assess subgroup effects based on specific medical conditions.

More on The Cognitive Effects of Cannabis 

Cannabis and Mental Health

Impact of CB1 and cognition

5 Ways Cannabidiol Alzheimer’s Treatment Benefits Brain Health